<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Muscle relaxants: anaesthesia: non-depolarising; Non-depolarising muscle relaxants see Muscle relaxants; Atracurium; Cisatracurium; Mivacurium; Pancuronium; Rocuronium; Vecuronium" /><meta name="IX" content="Muscle relaxants: anaesthesia: non-depolarising; Atracurium; Cisatracurium; Mivacurium; Pancuronium; Rocuronium; Vecuronium" /><meta name="IXN" content="Non-depolarising muscle relaxants see Muscle relaxants" /><title>Non-depolarising neuromuscular blocking drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP8607-non-depolarising-neuromuscular-blocking-drugs.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP8607-non-depolarising-neuromuscular-blocking-drugs.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP8607-non-depolarising-neuromuscular-blocking-drugs.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8494-anaesthesia.htm">15 Anaesthesia</a> &gt; <a href="PHP8495-general-anaesthesia.htm">15.1 General anaesthesia</a> &gt; <a href="PHP8605-neuromuscular-blocking-drugs.htm">15.1.5 Neuromuscular blocking drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP8605-neuromuscular-blocking-drugs.htm" title="Previous: 15.1.5 Neuromuscular blocking drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP8614-atracurium-besilate.htm" title="Next: ATRACURIUM BESILATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Non-depolarising neuromuscular blocking drugs</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int620-muscle-relaxants-non-depolarising.htm">Muscle Relaxants, non-depolarising</a>).</p></div></div><p>Non-depolarising neuromuscular blocking drugs (also known as competitive muscle relaxants) compete with acetylcholine for receptor sites at the neuromuscular junction and their action can be reversed with anticholinesterases such as neostigmine (<a title="BNF:monograph: NEOSTIGMINE METILSULFATE" href="PHP8641-neostigmine-metilsulfate.htm">section 15.1.6</a>). Non-depolarising neuromuscular blocking drugs can be divided into the <strong>aminosteroid</strong> group, comprising pancuronium, rocuronium, and vecuronium, and the <strong>benzylisoquinolinium</strong> group, comprising atracurium, cisatracurium, and mivacurium.</p> <p>Non-depolarising neuromuscular blocking drugs have a slower onset of action than suxamethonium. These drugs can be classified by their duration of action as short-acting (15–30 minutes), intermediate-acting (30–40 minutes), and long-acting (60–120 minutes), although duration of action is dose-dependent. Drugs with a shorter or intermediate duration of action, such as atracurium and vecuronium, are more widely used than those with a longer duration of action, such as pancuronium.</p> <p>Non-depolarising neuromuscular blocking drugs have no sedative or analgesic effects and are not considered to trigger malignant hyperthermia.</p> <p>For patients receiving intensive care and who require tracheal intubation and mechanical ventilation, a non-depolarising neuromuscular blocking drug is chosen according to its onset of effect, duration of action, and side-effects. Rocuronium, with a rapid onset of effect, may facilitate intubation. Atracurium or cisatracurium may be suitable for long-term neuromuscular blockade since their duration of action is not dependent on elimination by the liver or the kidneys.</p> <div id="PHP8608"><h2>Cautions</h2><p>Allergic cross-reactivity between neuromuscular blocking drugs has been reported; caution is advised in cases of hypersensitivity to these drugs. Their activity is prolonged in patients with myasthenia gravis and in hypothermia, and lower doses are required. Non-depolarising neuromuscular blocking drugs should be used with great care in those with other neuromuscular disorders and those with fluid and electrolyte disturbances, as response is unpredictable. Resistance can develop in patients with burns, who may require increased doses; low plasma cholinesterase activity in these patients requires dose titration for mivacurium. The rate of administration of neuromuscular blocking drugs should be reduced in patients with cardiovascular disease. <strong>Interactions:</strong> Appendix 1 (muscle relaxants).</p> </div> <div id="PHP8610"><h2>Pregnancy</h2><p>Non-depolarising neuromuscular blocking drugs are highly ionised at physiological pH and are therefore unlikely to cross the placenta in significant amounts.</p></div> <div id="PHP8611"><h2>Breast-feeding</h2><p>Because they are ionised at physiological pH, non-depolarising neuromuscular blocking drugs are unlikely to be present in milk in significant amounts. Breast-feeding may be resumed once the mother has recovered from neuromuscular block.</p></div> <div id="PHP8612"><h2>Side-effects</h2><p>Benzylisoquinolinium non-depolarising neuromuscular blocking drugs (except cisatracurium) are associated with histamine release, which can cause skin flushing, hypotension, tachycardia, bronchospasm, and very rarely anaphylactoid reactions. Most aminosteroid neuromuscular blocking drugs produce minimal histamine release. Drugs with vagolytic activity can counteract any bradycardia that occurs during surgery. Acute myopathy has also been reported after prolonged use in intensive care.</p></div> <p><strong>Atracurium</strong>, a mixture of 10 isomers, is a benzylisoquinolinium neuromuscular blocking drug with an intermediate duration of action. It undergoes non-enzymatic metabolism which is independent of liver and kidney function, thus allowing its use in patients with hepatic or renal impairment. Cardiovascular effects are associated with significant histamine release.</p> <p><strong>Cisatracurium</strong> is a single isomer of atracurium. It is more potent and has a slightly longer duration of action than atracurium and provides greater cardiovascular stability because cisatracurium lacks histamine-releasing effects.</p> <p><strong>Mivacurium</strong>, a benzylisoquinolinium neuromuscular blocking drug, has a short duration of action. It is metabolised by plasma cholinesterase and muscle paralysis is prolonged in individuals deficient in this enzyme. It is not associated with vagolytic activity or ganglionic blockade although histamine release can occur, particularly with rapid injection.</p> <p><strong>Pancuronium</strong>, an aminosteroid neuromuscular blocking drug, has a long duration of action and is often used in patients receiving long-term mechanical ventilation in intensive care units. It lacks a histamine-releasing effect, but vagolytic and sympathomimetic effects can cause tachycardia and hypertension.</p> <p><strong>Rocuronium</strong> exerts an effect within 2 minutes and has the most rapid onset of any of the non-depolarising neuromuscular blocking drugs. It is an aminosteroid neuromuscular blocking drug with an intermediate duration of action. It is reported to have minimal cardiovascular effects; high doses produce mild vagolytic activity.</p> <p><strong>Vecuronium</strong>, an aminosteroid neuromuscular blocking drug, has an intermediate duration of action. It does not generally produce histamine release and lacks cardiovascular effects.</p> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP8614-atracurium-besilate"><a href="PHP8614-atracurium-besilate.htm" title="ATRACURIUM BESILATE">ATRACURIUM BESILATE</a></li><li id="_PHP8617-cisatracurium"><a href="PHP8617-cisatracurium.htm" title="CISATRACURIUM">CISATRACURIUM</a></li><li id="_PHP8620-mivacurium"><a href="PHP8620-mivacurium.htm" title="MIVACURIUM">MIVACURIUM</a></li><li id="_PHP8622-pancuronium-bromide"><a href="PHP8622-pancuronium-bromide.htm" title="PANCURONIUM BROMIDE">PANCURONIUM BROMIDE</a></li><li id="_PHP8624-rocuronium-bromide"><a href="PHP8624-rocuronium-bromide.htm" title="ROCURONIUM BROMIDE">ROCURONIUM BROMIDE</a></li><li id="_PHP8627-vecuronium-bromide"><a href="PHP8627-vecuronium-bromide.htm" title="VECURONIUM BROMIDE">VECURONIUM BROMIDE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP8605-neuromuscular-blocking-drugs.htm">Previous: 15.1.5 Neuromuscular blocking drugs</a> | <a class="top" href="PHP8607-non-depolarising-neuromuscular-blocking-drugs.htm#">Top</a> | <a accesskey="]" href="PHP8614-atracurium-besilate.htm">Next: ATRACURIUM BESILATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>